Celcuity Inc.
CELCNASDAQ
Healthcare
Biotechnology
$114.16
+1.53(1.4%)
52W $8.21 – $117.25
Quick:
10-K
Mar 26, 2026 (1 weeks ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
SCHEDULE 13D/A
Mar 24, 2026 (1 weeks ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13G
Feb 17, 2026 (1 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Feb 12, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Feb 12, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Jan 16, 2026 (2 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Nov 17, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Nov 13, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
Nov 13, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13G/A
Nov 13, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Nov 12, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 20, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Sep 10, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Aug 18, 2025 (7 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Aug 14, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 14, 2025 (7 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13G
Aug 4, 2025 (8 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Aug 4, 2025 (8 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active